SCHEMBL10224640

SCHEMBL10224640

CCc1cn2cc(C(C)(C)C)ccc2n1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SCN10A Q9Y5Y9 1/20 0.48
KDM4E B2RXH2 4/20 0.41
TP53 P04637 1/20 0.41
MAP3K5 Q99683 8/20 0.40
CSNK1D P48730 1/20 0.39
CSNK1G2 P78368 1/20 0.39
MCHR1 Q99705 3/20 0.38
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
MAPT P10636 2/20 0.35
ALDH1A1 P00352 2/20 0.35
POLB P06746 1/20 0.35
HPGD P15428 1/20 0.35
NFKB1 P19838 1/20 0.35
GFER P55789 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
RCE1 Q9Y256 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22277159 0.85 KDM4E (0.50) KDM4ETP53MCHR1NPC1RAB9A
SCHEMBL13633339 0.78 NPC1 (0.52) KDM4ETP53NPC1RAB9AMAPT
SCHEMBL24944153 0.77 KDM4E (0.42) KDM4ETP53NPC1RAB9AMAPT
SCHEMBL2707031 0.77 MCHR1 (0.49) SCN10AKDM4ETP53MAP3K5CSNK1D
SCHEMBL15828624 0.77 SCN10A (0.48) SCN10AKDM4ETP53MAP3K5CSNK1D
SCHEMBL10222603 0.77 KDM4E (0.44) KDM4ETP53NPC1RAB9AMAPT
SCHEMBL29304400 0.76 KDM4E (0.41) SCN10AKDM4ETP53MCHR1NPC1
SCHEMBL1500151 0.75 PIK3CG (0.55) KDM4ETP53MAP3K5NPC1RAB9A
SCHEMBL20713612 0.75 APP (0.46) KDM4ETP53NPC1RAB9AMAPT
SCHEMBL8814958 0.75 KDM4E (0.68) KDM4ETP53NPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8338437-B2 Methyl transferase inhibitors; antiproliferative agents; antiinflammatory agents; immunotherapy; infection therapy METHYLGENE INC. (CA) 2012-12-25 US disclosed
US-8088791-B2 Antibacterial agents Biots Scientific Management Pty Ltd (AU) 2012-01-03 US disclosed
US-20100173933-A1 ANTIBACTERIAL AGENTS PROLYSIS LTD (GB) 2010-07-08 US disclosed
US-20080280925-A1 Amines as Small Molecule Inhibitors METHYLGENE INC. 2008-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080280925-A1 Amines as Small Molecule Inhibitors CARM1, PRMT1, PRMT3 SCN10A 2990/4885KDM4E 369/4885TP53 559/4885
US-20100173933-A1 ANTIBACTERIAL AGENTS ALK, ROS1, NOX1 SCN10A 1246/4885KDM4E 2407/4885TP53 4103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.